Helping patients take medications effectively is a key clinical undertaking. Optimal medication adherence improves clinical outcomes and can even lower health care costs by reducing morbidity and decreasing health care use.1  Benefits are especially striking in patients with diabetes.2,3 Across chronic illnesses, patients take only ∼ 50% of medications prescribed for those conditions.4,5 Similar patterns are seen in patients with diabetes,6 particularly in those who also have depressive symptoms. Among depressed patients with diabetes, for example, nonadherence to hypoglycemic and antihypertensive agents is even lower than among nondepressed patients with diabetes.7,8 Even among nondepressed patients, levels of medication adherence may be significantly lower than desired because of side effects and lack of motivation to take the medications as prescribed.

Figure 1.

Sample preprinted label. Photo courtesy of J. Dudl, Kaiser Permanente Care Management Institute for Diabetes.

Figure 1.

Sample preprinted label. Photo courtesy of J. Dudl, Kaiser Permanente Care Management Institute for Diabetes.

Close modal

Patients, health care providers, and health care systems all play a role in creating this quality and outcome gap between current reality and optimal diabetes management.9,10 Barriers to effective use of medicines for diabetes care include: 1)poor provider-patient communication; 2) inadequate knowledge about a drug and its use (in both patients and clinicians); 3) psychological insulin resistance;11 4) complex regimens that require numerous medications with varying dosing schedules; 5) lack of follow-up to monitor treatment response; 6) lack of treatment titration to achieve optimal outcomes; and 7) cost and access barriers.9,12,13 

The current lack of provider time and shortage of clinic resources to support good chronic illness care for diabetes further widens the quality gap. Additional health care system supports are necessary to reduce cost and access barriers and to enhance appropriate intensification of treatment and follow-up(barriers 5-7). Nevertheless, primary care physicians and teams can use evidence-based approaches for increasing collaboration with their patients as a way for improving adherence and clinical outcomes. The following clinical actions summarize systematic reviews of the literature and combine patient-centered approaches aimed at achieving better medication adherence and diabetes outcomes.9,12,14-16 

Diabetes-related choices that patients make each day may have more impact than physicians' recommendations alone on how well diabetes is managed. Nevertheless, at the time of health care visits, offering information,education, and steps to motivate patients about their diabetes self-care behaviors—glucose monitoring, healthy nutrition, physical activity, and medication taking—is key for optimal management. In other words,patients are in charge of managing their diabetes, but clinicians are important advisors and can provide assistance and support. Thus, providers have an important role that is best accomplished in a patient-provider or patient-health team partnership.

If possible, include family members and audiovisual aids at the time of initial prescribing of a medication. Address the key information (what, why,when, how, and how long) as follows:

  • Name of the medicine

  • Its purpose and potential role in reducing diabetes complications

  • The number of tablets or units per injection of a dose and the frequency of dosing

  • Its duration, daily and in the long term

  • Common side effects or adverse effects

Simple written information and instructions, in addition to verbal instructions, are necessary. Large preprinted labels can be affixed to the medication container for easy reference(Figure 1).

  • Anticipate that patients often do not “take medication as prescribed.”

  • Express understanding or empathy that “taking medication as prescribed” is often difficult and may not be possible for many patients.

  • Recognize likely red flags of nonadherence (e.g., lack of response to treatment, missed appointments, and missed refills).

  • Ask patients in a nonjudgmental manner how often they miss taking doses of medicine and about their actual medication taking (e.g., “How many tablets are you taking and when?”).

  • Minimize the number of doses/injections to once daily whenever possible.

  • Minimize the number of pills per day.

  • Synchronize simultaneous dosing of different medicines unless contraindicated.

  • Select more forgiving medications (e.g., those that lead to fewer hypoglycemic reactions).

Keep in mind that reducing the frequency of dosing is more important than the number of pills in a dose.

Figure 2.

Medication “bubble pack.”

Figure 2.

Medication “bubble pack.”

Close modal
Figure 3.

Medication sets to organize a week's supply of medications. Photos courtesy of E. Lin, Center for Health Studies, Group Health Cooperative.

Figure 3.

Medication sets to organize a week's supply of medications. Photos courtesy of E. Lin, Center for Health Studies, Group Health Cooperative.

Close modal
  • Identify patient fears and beliefs, such as those related to psychological insulin resistance17  (e.g.,many patients view starting insulin as a sign of their failure to control diabetes or as a sign of impending death).

  • Identify and seek solutions to cost and access barriers to taking medications.

  • Help to identify daily reminders. Collaborate with patients to identify a daily action in their routine that serves as a prompt to take medicine (e.g.,brushing teeth or turning out the light at bedtime).

  • Suggest aids. Medication sets that can be prefilled provide easy,organized, and ready access to a weekly supply of medications. A variation on this theme is the “bubble pack,” which is a sealed set of medications with daily medications that is customized by the patient's pharmacy (Figures 2 and 3).

  • Assess treatment response.

  • Reassess adherence and difficulties with medication-taking.

  • Problem-solve difficulties using patients' preferences and solutions.

  • Adjust treatment to achieve optimal outcome.

  • Facilitate medication refills and follow-up care.

Optimal diabetes care is achievable if clinicians collaborate with patients in managing diabetes and if health care systems support systematic patient response monitoring and enhance treatment titration to achieve favorable diabetes outcomes with minimal complications. A first step in working with patients is recognizing that not “taking medications as directed”is common. Useful clinical encounters and approaches include a nonjudgmental assessment of medication-taking, clear explanations about how to use medications, simplified regimens, and scheduled follow-up visits or telephone calls to monitor progress and adjust treatment. Such practical approaches are ones that health care providers and patients can use in a busy primary care setting.

Elizabeth H.B. Lin, MD, MPH, is a family medicine physician and affiliate scientific investigator at the Center for Health Studies, Group Health Cooperative in Seattle, Wash. She is also a clinical professor. Paul Ciechanowski, MD, MPH, is an associate professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine in Seattle.

1.
Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS: Impact of medication adherence on hospitalization risk and healthcare cost.
Med Care
43
:
521
-530,
2005
2.
Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ: Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus.
Arch Intern Med
166
:
1836
-1841,
2006
3.
Rhee MK, Slocum W,Ziemer DC, Culler SD, Cook CB, El-Kebbi IM, Gallina DL, Barnes C, Phillips LS:Patient adherence improves glycemic control.
Diabetes Educ
31
:
240
-250,
2005
4.
Haynes RB,McDonald HP, Garg AX: Helping patients follow prescribed treatment: clinical applications.
JAMA
288
:
2880
-2883,
2002
5.
DiMatteo MR,Giordani PJ, Lepper HS, Croghan TW: Patient adherence and medical treatment outcomes: a meta-analysis.
Med Care
40
:
794
-811,
2002
6.
Rubin RR:Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus.
Am J Med
118
(
Suppl. 5A
):
27S
-34S,
2005
7.
Lin EHB, Katon WVKM, Rutter C, Simon GE, Oliver M, Ciechanowski P, Ludman E, Bush T, Young B:Relationship of depression and diabetes self-care, medication adherence and preventive care.
Diabetes Care
27
:
2154
-2160,
2004
8.
Ciechanowski PS,Katon WJ, Russo JE: Depression and diabetes: impact of depressive symptoms on adherence, function, and costs.
Arch Intern Med
160
:
3278
-3285,
2000
9.
Osterberg L,Blaschke T: Adherence to medication.
N Engl J Med
353
:
487
-497,
2005
10.
Wagner EH, Glasgow RE, Davis C, Bonomi AE, Provost L, McCulloch D, Carver P, Sixta C: Quality improvement in chronic illness care: a collaborative approach.
Jt Comm J Qual Improv
27
:
63
-80,
2001
11.
Polonsky WH,Fisher L, Guzman S, Villa-Caballero L, Edelman SV: Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem.
Diabetes Care
28
:
2543
-2545,
2005
12.
Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS: Physician communication when prescribing new medications.
Arch Intern Med
166
:
1855
-1862,
2006
13.
Rodondi N, Peng T,Karter AJ, Bauer DC, Vittinghoff E, Tang S, Pettitt D, Kerr EA, Selby JV:Therapy modifications in response to poorly controlled hypertension,dyslipidemia, and diabetes mellitus.
Ann Intern Med
144
:
475
-484,
2006
14.
Glasgow RE, Davis CL, Funnell MM, Beck A: Implementing practical interventions to support chronic illness self-management.
Jt Comm J Qual Saf
29
:
563
-574,
2003
15.
Funnell MM, Kruger DF, Spencer M: Self-management support for insulin therapy in type 2 diabetes.
Diabetes Educ
30
:
274
-280,
2004
16.
Kripalani S, Yao X, Haynes RB: Interventions to enhance medication adherence in chronic medical conditions: a systematic review.
Arch Intern Med
167
:
540
-549,
2007
17.
Polonsky WH,Earles J, Smith S, Pease DJ, Macmillan M, Christensen R, Taylor T, Dickert J,Jackson RA: Integrating medical management with diabetes self-management training: a randomized control trial of the Diabetes Outpatient Intensive Treatment program.
Diabetes Care
26
:
3048
-3053,
2003